Skip to main content

Alexion Pharmaceuticals, Inc.

ALXNDelisted Jul 21, 2021
Industry
Pharmaceutical Preparations
SEC CIK
0000899866

Alexion Pharmaceuticals, Inc. was delisted on Jul 21, 2021; its insiders filed their last Form 4 on Jul 23, 2021; 711 institutions reported holding it in 13F filings for Q2 2021, worth $39.1B in total; superinvestors Soros Fund Management and Maverick Capital held it.

13F holders, Q1 2021

Institutional positions in Alexion Pharmaceuticals, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
755
No complete 13F data for Q4 2020
Shares held
204.6M
No complete 13F data for Q4 2020
Total value
$31.3B
No complete 13F data for Q4 2020

Holders and value by quarter

Institutions reporting ALXN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2021: 755 institutions
Q1 2021: 755 institutionsQ2 2021: 711 institutionsQ3 2021: 7 institutionsQ4 2021: 2 institutionsQ1 2022: 1 institutionQ2 2022: 1 institutionQ3 2022: 1 institutionQ4 2022: 1 institutionQ1 2023: 1 institutionQ2 2023: 1 institutionQ3 2023: 1 institutionQ4 2023: 1 institutionQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 1 institutionQ1 2025: 0 institutionsQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 2 institutionsQ2 2026: 0 institutions
Value heldQ1 2021: $31.3B
Q1 2021: $31.3BQ2 2021: $39.1BQ3 2021: $823.0KQ4 2021: $14.0KQ1 2022: $13.0KQ2 2022: $13.0KQ3 2022: $16.0KQ4 2022: $13.0KQ1 2023: $13.0KQ2 2023: $13.6KQ3 2023: $10.4KQ4 2023: $8.83KQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $924.0KQ1 2025: $0Q2 2025: $5.52KQ3 2025: $5.79KQ4 2025: $5.40KQ1 2026: $2.16MQ2 2026: $0
Institutions holding ALXN and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20262$2.16M
Q4 20251$5.40K
Q3 20251$5.79K
Q2 20251$5.52K
Q1 20250$0
Q4 20241$924.0K
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20231$8.83K
Q3 20231$10.4K
Q2 20231$13.6K
Q1 20231$13.0K
Q4 20221$13.0K
Q3 20221$16.0K
Q2 20221$13.0K
Q1 20221$13.0K
Q4 20212$14.0K
Q3 20217$823.0K
Q2 2021711$39.1B
Q1 2021755$31.3B

Institutions, Q1 2021

Shares, value and share of portfolio for each institution holding Alexion Pharmaceuticals, Inc..

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.

Institutions holding ALXN in Q1 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Swiss National Bank841,931$128.7M0.09%––
Bank of America Corp942,830$144.2M0.02%––
Taconic Capital Advisors LP980,000$149.9M6.90%––
DnB Asset Management AS988,883$151.2M1.10%––
Hudson Bay Capital Management LP1,000,522$153.0M2.16%––
Omni Partners LLP1,003,383$153.4M7.58%––
Charles Schwab Investment Management Inc1,033,583$158.0M0.06%––
Alpine Associates Management Inc.1,045,700$159.9M4.34%––
PFM Health Sciences, LP1,059,631$162.0M5.64%––
Sand Grove Capital Management LLP1,067,391$163.2M15.95%––
UBS Asset Management Americas Inc1,067,481$163.2M0.07%––
Bank of Nova Scotia1,072,579$164.0M0.32%––
D. E. Shaw & Co., Inc.1,079,085$165.0M0.20%––
Invesco Ltd.1,139,063$174.2M0.05%––
Capstone Investment Advisors, LLC1,177,499$180.1M5.42%––
Capitolis Advisors LLC1,241,621$189.9M3.28%––
Magnetar Financial LLC1,289,848$197.2M1.90%––
Westchester Capital Management, LLC1,305,536$199.6M5.95%––
Bellevue Group AG1,308,728$200.1M2.12%––
Dimensional Fund Advisors LP1,315,940$201.1M0.07%––
Credit Suisse AG1,371,621$209.7M0.15%––
Swedbank AB1,391,278$212.7M0.44%––
Paulson & Co. Inc.1,400,000$214.1M4.92%––
Manufacturers Life Insurance Company, The1,414,293$216.3M0.19%––
Legal & General Group Plc1,442,966$220.6M0.08%––
Alliancebernstein L.P.1,472,777$225.2M0.10%––
PSquared Asset Management AG1,480,423$226.4M19.57%––
Pictet Asset Management Ltd1,564,739$239.3M0.29%––
UBS Oconnor LLC1,566,773$239.6M3.46%––
Natixis1,656,500$253.3M0.83%––
Morgan Stanley1,800,193$275.3M0.04%––
Bank of New York Mellon Corp1,813,666$277.3M0.06%––
Franklin Resources Inc1,890,669$289.1M0.12%––
Sculptor Capital LP2,022,374$309.2M2.74%––
Norges Bank2,223,092$339.9M0.08%––
JPMorgan Chase & Co2,264,381$346.2M0.05%––
Deutsche Bank AG2,279,545$348.6M0.19%––
Citadel Advisors LLC2,503,172$382.8M0.40%––
Millennium Management LLC2,552,539$390.3M0.55%––
LSV Asset Management2,599,382$397.5M0.68%––
Northern Trust Corp2,710,339$414.4M0.08%––
Citigroup Inc3,282,272$501.9M0.48%––
Renaissance Technologies LLC3,328,121$508.9M0.63%––
FMR LLC3,528,087$539.5M0.05%––
Barclays PLC3,578,376$547.2M0.53%––
Geode Capital Management, LLC3,969,950$605.5M0.09%––
Baker Bros. Advisors LP3,993,312$610.6M2.65%––
Davidson Kempner Capital Management LP4,064,176$621.1M6.24%––
Adage Capital Partners GP, L.L.C.4,242,379$648.7M1.32%––
Pentwater Capital Management LP4,289,244$655.9M7.60%––
HBK Investments L P5,725,000$875.4M10.32%––
Farallon Capital Management, L.L.C.5,775,000$883.1M4.59%––
State Street Corp9,877,534$1.51B0.09%––
BlackRock Inc.17,550,295$2.68B0.08%––
Vanguard Group Inc19,568,983$2.99B0.08%––